Ing. Daniel Buša
Research specialist, Department of Internal Medicine, Hematology and Oncology
correspondence Address:
Jihlavská 340/20, 625 00 Brno
office: bldg. F01B2/156
Kamenice 126/3
625 00 Brno
| phone: | +420 549 49 5437 |
|---|---|
| e‑mail: |
| social and academic networks: |
|---|
Total number of publications: 16
2025
-
Robust acute myeloid leukemia engraftment in humanized scaffolds using injectable biomaterials and intravenous xenotransplantation
Molecular oncology, year: 2025, DOI
2024
-
ANALYSIS OF ALTERNATIVE THERAPEUTIC OPTIONS FOR ACUTE MYELOID LEUKEMIA PATIENTS RESISTANT TO VENETOCLAX BASED ON DRUG SCREENING AND EXPRESSION PROFILING
Year: 2024, type: Conference abstract
-
IDENTIFICATION OF CHRONIC MYELOID LEUKEMIA STEM CELLS AT DIAGNOSIS AND EARLY FOLLOW-UP
Year: 2024, type: Conference abstract
-
Novel casein kinase 1 alpha inhibitors for the treatment of resistant AML and solid tumors
Year: 2024, type: Conference abstract
-
ROBUST ACUTE MYELOID LEUKEMIA ENGRAFTMENT IN HUMANIZED SCAFFOLDS USING INJECTABLE BIOMATERIALS AND INTRAVENOUS XENOTRANSPLANTATION
Year: 2024, type: Conference abstract
2023
-
AML engraftment in humanized ossicles is not governed by biomaterial selection.
Year: 2023, type: Conference abstract
-
Biomaterial selection does not affect AML engraftment in humanized ossicles.
Year: 2023, type: Conference abstract
-
Identificationof novel therapeutic options for venetoclax-resistant AML cells through drug repurposing.
Year: 2023, type: Conference abstract
-
Inhibition of acute myeloid leukemia using palbociclib and ponatinib in a patient-derived xenograft model.
Year: 2023, type: Conference abstract
2022
-
. Drug repurposing for venetoclax-resistant acute myeloid leukemia.
Year: 2022, type: Conference abstract